These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 8772902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
    Mitchison DA.
    Am J Respir Crit Care Med; 2003 May 15; 167(10):1298-9. PubMed ID: 12738593
    [No Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 15; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S, Detjen A, Wahn U, Magdorf K.
    Int J Tuberc Lung Dis; 2008 Sep 15; 12(9):1099-101. PubMed ID: 18713511
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of rifampicin and isoniazid in tuberculosis.
    Seth V, Beotra A, Seth SD, Semwal OP, Kabra S, Jain Y, Mukhopadhya S.
    Indian Pediatr; 1993 Sep 15; 30(9):1091-8. PubMed ID: 8125594
    [Abstract] [Full Text] [Related]

  • 8. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov 15; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

  • 9. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
    Zwolska Z, Augustynowicz-Kopeć E, Niemirowska-Mikulska H.
    Acta Pol Pharm; 2002 Nov 15; 59(6):448-52. PubMed ID: 12669769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 15; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
    Qurrat-ul-Ain, Sharma S, Khuller GK, Garg SK.
    J Antimicrob Chemother; 2003 Apr 15; 51(4):931-8. PubMed ID: 12654730
    [Abstract] [Full Text] [Related]

  • 15. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
    Fahimi F, Tabarsi P, Kobarfard F, Bozorg BD, Goodarzi A, Dastan F, Shahsavari N, Emami S, Habibi M, Salamzadeh J.
    Int J Tuberc Lung Dis; 2013 Dec 15; 17(12):1602-6. PubMed ID: 24200276
    [Abstract] [Full Text] [Related]

  • 16. Effect of simultaneous isoniazid administration on pharmacokinetic parameters of pyrazinamide.
    Singhal KC, Varshney MK.
    J Indian Med Assoc; 1991 Aug 15; 89(8):227-9. PubMed ID: 1748799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 15; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 19. [Short term treatment of infantile pulmonary tuberculosis].
    Garciá López JR, Vidal López ML, Castán Vidal ML, Borque Andrés C, de José Gómez MI, García Hortelano J.
    An Esp Pediatr; 1989 Aug 15; 31(2):110-3. PubMed ID: 2696390
    [Abstract] [Full Text] [Related]

  • 20. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
    Singh S, Mohan B.
    Int J Tuberc Lung Dis; 2003 Mar 15; 7(3):298-303. PubMed ID: 12661847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.